Osteoarthritis Therapeutics Market Explored by Daedal Research in Its Cutting-edge Report Now Available at MarketPublishers.com

29 Nov 2016 • by Natalie Aster

LONDON – Osteoarthritis (OA) is usually diagnosed in the middle-aged and elderly people, it is a sluggishly progressive joint disease. Osteoarthritis is caused by the breakdown of the joint cartilage owing to biochemical alterations or mechanical stress, which results in the fail of bone underneath. 

Osteoarthritis could also occur along with other types of arthritis, for instance, gout or rheumatoid arthritis (RA).

This disease usually affects commonly used joints like spine and hand and also weight-bearing joints like knees and hips.

The causes of osteoarthritis are still not fully understood, but genetic factors and damage to the joints both through repeated excessive loading and stress of a joint over time as well as by injury increases the risk of developing osteoarthritis.

At present, there is no any single test to diagnose osteoarthritis. However, several methods are applied to diagnose this disease and rule out other problems such as physical exam, medical history, blood tests, X-rays and joint fluid analysis. Structural changes, occurring with old age, may not be accompanied by symptoms, which makes the estimation of the osteoarthritis prevalence difficult.

New report “OpportunityAnalyzer: Osteoarthritis - Opportunity Analysis and Forecasts to 2024” by GlobalData offers unique top-level data on the performance of the world’s market for osteoarthritis therapeutics.

It contains info on osteoarthritis etiology, epidemiology, symptoms, pathophysiology, diagnosis and also treatment options.

The report comprises historical data for the market performance as well as outlines future possible growth trends and opportunities. It includes info on market revenues, volume, value, segments, shares, treatment usage patterns and annual costs of therapy.

The research study includes info on competitive pressures, key growth drivers and limiters, unmet needs, clinical trials and development of new therapies for osteoarthritis.

This insightful research report features the current market scenario, explores the major factors shaping the market and also presents forecasts of the market development through 2025.

For other research studies prepared by this publisher visit the GlobalData page at MarketPublishers.com.

CONTACTS

The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
ps@marketpublishers.com
MarketPublishers.com